With coronavirus cases continuing to rise worldwide, blood-health company, Versiti, is seeking plasma from recovered COVID-19 patients to treat community members diagnosed with the virus. According to the New York Times, nearly 60,000 cases of COVID-19 are being diagnosed daily, leading to high demand for convalescent plasma. In addition to severely affected patients, this treatment is also being used in patients earlier in their illness to limit progression of the effects of the virus. This unique plasma treatment transfers the antibodies from a recovered COVID-19 patient into critically ill patients currently receiving care. Because of the investigational nature of this treatment, it is difficult to predict how many plasma infusions a COVID-19 patient may require, but Versiti is working with partnered hospitals in identifying recovered patients in the area and asking for donations from those recovered patients.